Literature DB >> 11812285

In vitro-packaged SV40 pseudovirions as highly efficient vectors for gene transfer.

Chava Kimchi-Sarfaty1, Orly Ben-Nun-Shaul, Deborah Rund, Ariella Oppenheim, Michael M Gottesman.   

Abstract

A procedure for in vitro packaging of plasmid DNA in recombinant SV40 capsid proteins was developed by Sandalon et al. (1997). Here, we report the highly efficient transduction into different human, murine and monkey cell lines using a scaled-up protocol for producing SV40 pseudovirions, packaged in vitro, carrying the human multidrug-resistance gene MDR1 encoding P-glycoprotein (P-gp) or the green fluorescent protein reporter gene (GFP) under control of SV40 and cytomegalovirus (CMV) promoters. The percentage of expressing cells was proportional to the number of transducing particles, with close to 100% of cells transduced at optimal ratios of transducing particles to cells. The ability to confer multidrug resistance was evaluated by measuring dye efflux and cell-surface expression in infected cells. The relative level of expression of P-gp driven by the different promoters varied among different cell lines. In human lymphoblastoid cells, which express high levels of major histocompatibility complex (MHC) class I (a surface receptor for SV40), constructs that carry an intron yield the highest expression. Our experiments further demonstrate that MDR1 and GFP expression driven by these promoters is transient; however, transduced cells remain MDR1-positive if selected in colchicine. Thus, the SV40 vectors are well suited to situations in which only short-term expression is required or expression is selected, such as for bone marrow protection during chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11812285     DOI: 10.1089/10430340252769815

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  13 in total

1.  Differential assembly of Hepatitis B Virus core protein on single- and double-stranded nucleic acid suggest the dsDNA-filled core is spring-loaded.

Authors:  Mary S Dhason; Joseph C-Y Wang; Michael F Hagan; Adam Zlotnick
Journal:  Virology       Date:  2012-05-16       Impact factor: 3.616

2.  Efficient delivery of RNA interference effectors via in vitro-packaged SV40 pseudovirions.

Authors:  Chava Kimchi-Sarfaty; Scott Brittain; Susan Garfield; Natasha J Caplen; Qingquan Tang; Michael M Gottesman
Journal:  Hum Gene Ther       Date:  2005-09       Impact factor: 5.695

3.  RNA encapsidation by SV40-derived nanoparticles follows a rapid two-state mechanism.

Authors:  Stanislav Kler; Roi Asor; Chenglei Li; Avi Ginsburg; Daniel Harries; Ariella Oppenheim; Adam Zlotnick; Uri Raviv
Journal:  J Am Chem Soc       Date:  2012-03-13       Impact factor: 15.419

4.  Effect of dsDNA on the Assembly Pathway and Mechanical Strength of SV40 VP1 Virus-like Particles.

Authors:  Mariska G M van Rosmalen; Chenglei Li; Adam Zlotnick; Gijs J L Wuite; Wouter H Roos
Journal:  Biophys J       Date:  2018-09-13       Impact factor: 4.033

Review 5.  Long-term gene expression in dividing and nondividing cells using SV40-derived vectors.

Authors:  David S Strayer; Lokesh Agrawal; Pierre Cordelier; Bianling Liu; Jean-Pierre Louboutin; Elena Marusich; Hayley J McKee; Carmen N NiGongyi Ren; Marlene S Strayer
Journal:  Mol Biotechnol       Date:  2006-10       Impact factor: 2.860

6.  Inhibition of multidrug resistance by SV40 pseudovirion delivery of an antigene peptide nucleic acid (PNA) in cultured cells.

Authors:  Benjamin Macadangdang; Ning Zhang; Paul E Lund; Andrew H Marple; Mitsunori Okabe; Michael M Gottesman; Daniel H Appella; Chava Kimchi-Sarfaty
Journal:  PLoS One       Date:  2011-03-22       Impact factor: 3.240

Review 7.  The ABCB1, ABCC2 and RALBP1 polymorphisms are associated with carbamazepine response in epileptic patient: a systematic review.

Authors:  Wefa Boughrara; Amina Chentouf
Journal:  Acta Neurol Belg       Date:  2022-03-24       Impact factor: 2.471

8.  Generation of a Vero-Based Packaging Cell Line to Produce SV40 Gene Delivery Vectors for Use in Clinical Gene Therapy Studies.

Authors:  Miguel G Toscano; Jeroen van der Velden; Sybrand van der Werf; Machteld Odijk; Ana Roque; Rafael J Camacho-Garcia; Irene G Herrera-Gomez; Irene Mancini; Peter de Haan
Journal:  Mol Ther Methods Clin Dev       Date:  2017-07-05       Impact factor: 6.698

9.  SV40 Pseudovirion gene delivery of a toxin to treat human adenocarcinomas in mice.

Authors:  C Kimchi-Sarfaty; W D Vieira; D Dodds; A Sherman; R J Kreitman; S Shinar; M M Gottesman
Journal:  Cancer Gene Ther       Date:  2006-02-24       Impact factor: 5.854

10.  Simian virus 40 vectors for pulmonary gene therapy.

Authors:  Luminita Eid; Zohar Bromberg; Mahmoud Abd El-Latif; Evelyn Zeira; Ariella Oppenheim; Yoram G Weiss
Journal:  Respir Res       Date:  2007-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.